Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma. | Sci Rep | 2023 | 37072474 | PubTator, text mining | PubMed |
| Development and validation of a gene-based classification model for pN2 lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 37057107 | PubTator, text mining | PubMed |
| NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. | Cancers (Basel) | 2023 | 37046733 | PubTator, text mining | PubMed |
| Circular forms of dedicator of cytokinesis 1 promotes breast cancer progression by derepressing never in mitosis related kinase 2 via sponging miR-128-3p. | Environ Toxicol | 2023 | 37040338 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation. | Mol Med | 2023 | 37016317 | PubTator, text mining | PubMed |
| Identification of dynamic gene expression profiles during sequential vaccination with ChAdOx1/BNT162b2 using machine learning methods. | Front Microbiol | 2023 | 37007526 | PubTator, text mining | PubMed |
| Cholesterol in the ciliary membrane as a therapeutic target against cancer. | Front Mol Biosci | 2023 | 37006607 | PubTator, text mining | PubMed |
| Systematic Review on the Metabolic Interest of Glucosinolates and Their Bioactive Derivatives for Human Health. | Nutrients | 2023 | 36986155 | PubTator, text mining | PubMed |
| Demystifying the Role of Prognostic Biomarkers in Breast Cancer through Integrated Transcriptome and Pathway Enrichment Analyses. | Diagnostics (Basel) | 2023 | 36980449 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers for Breast Cancer Metastasis Using Penalized Additive Hazards Regression Model. | Cancer Inform | 2023 | 36968522 | PubTator, text mining | PubMed |
Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents. | Clin Transl Med | 2023 | 36967563 | PubTator, text mining | PubMed |
| Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. | J Transl Med | 2023 | 36941602 | PubTator, text mining | PubMed |
| Deep thermal profiling for detection of functional proteoform groups. | Nat Chem Biol | 2023 | 36941476 | PubTator, text mining | PubMed |
| Appearing and disappearing acts of cilia. | J Biosci | 2023 | 36924208 | PubTator, text mining | PubMed |
| Revisiting the inhibitory potential of protein kinase inhibitors against NEK7 protein via comprehensive computational investigations. | Sci Rep | 2023 | 36922575 | PubTator, text mining | PubMed |
| Human Polo-like Kinase Inhibitors as Antiplasmodials. | ACS Infect Dis | 2023 | 36919909 | PubTator, text mining | PubMed |
| Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer. | Transl Androl Urol | 2023 | 36915888 | PubTator, text mining | PubMed |
| CENPF promotes the proliferation of renal cell carcinoma in vitro. | Transl Androl Urol | 2023 | 36915885 | PubTator, text mining | PubMed |
| From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer. | Front Genet | 2023 | 36911405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=14